RSP - Liver disease

32360995 ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
32278005 ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study
32348791 ä. Clinical characteristics of COVID-19 patients with abnormal liver tests
32348790 ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
32305291 ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
C7187739 ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa
32251539 2020. COVID-19 and liver disease
32389521 2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience
32329563 2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study